Aug 6, 2026 08:00AM
Jul 28, 2026 08:03AM
Jul 28, 2026 08:00AM
Jul 6, 2026 08:01AM
Jul 6, 2026 08:00AM
May 26, 2026 07:00AM
May 26, 2026 07:00AM Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers
May 14, 2026 08:01AM
May 14, 2026 08:00AM
May 12, 2026 08:00AM
May 5, 2026 08:00AM
Apr 22, 2026 08:00AM
Apr 7, 2026 02:49PM
Apr 7, 2026 08:06AM Corbus receives FDA alignment on registration path for cancer drug CRB-701
Apr 7, 2026 08:00AM
Mar 9, 2026 07:30AM
Nov 12, 2025 08:00AM
Oct 20, 2025 08:18AM
Oct 20, 2025 06:56AM
Oct 18, 2025 03:00AM
Oct 14, 2025 08:01AM Corbus Pharmaceuticals to present CRB-701 cancer drug data at ESMO
Oct 14, 2025 08:00AM
Sep 18, 2025 06:39AM
Sep 16, 2025 08:01AM
Sep 16, 2025 08:00AM
Sep 11, 2025 08:18AM
Aug 5, 2025 08:00AM
May 7, 2025 07:17AM Corbus Pharmaceuticals (CRBP) PT Lowered to $40 at H.C. Wainwright
May 6, 2025 08:00AM
Mar 12, 2025 06:40AM
Mar 11, 2025 08:00AM
Jan 2, 2025 12:51PM
Dec 3, 2024 07:00AM
Dec 3, 2024 07:00AM
Aug 6, 2024 08:00AM Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
May 7, 2024 08:00AM
Apr 24, 2024 04:05PM
Apr 2, 2024 08:00AM
Mar 12, 2024 08:00AM
Jan 26, 2024 07:30AM
Jan 26, 2024 07:30AM
Jan 23, 2024 08:00AM Phase 1 Clinical Data for SYS6002 (CRB-701) to be presented at 2024 ASCO GU
Jan 9, 2024 08:00AM
Dec 18, 2023 08:00AM
Nov 7, 2023 08:00AM
Oct 3, 2023 08:00AM
Aug 8, 2023 08:00AM
May 9, 2023 08:00AM
Feb 13, 2023 06:56AM Corbus Pharma (CRBP) Adds Clinical Stage Nectin-4 targeting Antibody Drug Conjugate
Feb 13, 2023 06:55AM

327,748 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All